3rd Quarter - Report

THE MCMANUS GROUP for NOVARTIS

Firm
Client
Income
$50,000
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Policies to promote innovative medical products in H.R. 2430 / S.934 - FDA Reauthorization Act of 2017

Foreign entity interest: Novartis AG, Fabrikstrasse 2, 4056 Basel, Switzerland

LobbyistCovered position, as disclosed
JOHN MCMANUS —
BARRETT THORNHILL —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: S. 934 (115th), H.R. 2430 (115th)

Medicare/Medicaid MMM

Pharmaceutical coverage and access in Parts A, B, C, and D. Advocacy regarding access to 340B reimbursement.

Foreign entity interest: Novartis AG, Fabrikstrasse 2, 4056 Basel, Switzerland

LobbyistCovered position, as disclosed
JOHN MCMANUS —
BARRETT THORNHILL —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.